These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 12404820)

  • 21. Epidemiology and clinical characteristics of classic Kaposi's sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: a critical review of an old disease.
    Mohanna S; Maco V; Bravo F; Gotuzzo E
    Int J Infect Dis; 2005 Sep; 9(5):239-50. PubMed ID: 16095940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Linking the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to human malignancies.
    Kalt I; Masa SR; Sarid R
    Methods Mol Biol; 2009; 471():387-407. PubMed ID: 19109790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AIDS-related Kaposi's sarcoma: principal pathogenic mechanisms.
    Silvestris N
    J Exp Clin Cancer Res; 1999 Sep; 18(3):311-5. PubMed ID: 10606175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission.
    Kedes DH; Operskalski E; Busch M; Kohn R; Flood J; Ganem D
    Nat Med; 1996 Aug; 2(8):918-24. PubMed ID: 8705863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kaposi's sarcoma triggered by endogenous HHV-8 reactivation after non-myeloablative allogeneic haematopoietic transplantation.
    Bruno B; Sorasio R; Barozzi P; Vieira J; Omedè P; Giaretta F; Rotta M; Giaccone L; Massaia M; Luppi M; Boccadoro M
    Eur J Haematol; 2006 Apr; 76(4):342-7. PubMed ID: 16519707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of environmental factors in the pathogenesis of classic and African-endemic Kaposi sarcoma.
    Simonart T
    Cancer Lett; 2006 Nov; 244(1):1-7. PubMed ID: 16542773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immunomodulatory factors of arthropod saliva and the potential for these factors to serve as vaccine targets to prevent pathogen transmission.
    Titus RG; Bishop JV; Mejia JS
    Parasite Immunol; 2006 Apr; 28(4):131-41. PubMed ID: 16542315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transmission of human herpesvirus 8: an update.
    Pica F; Volpi A
    Curr Opin Infect Dis; 2007 Apr; 20(2):152-6. PubMed ID: 17496573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-talk between human herpesvirus 8 and the transactivator protein in the pathogenesis of Kaposi's sarcoma in HIV-infected patients.
    Chandra A; Demirhan I; Massambu C; Pyakurel P; Kaaya E; Enbom M; Urassa W; Linde A; Heiden T; Biberfeld P; Doerr HW; Cinatl J; Loewer J; Chandra P
    Anticancer Res; 2003; 23(1B):723-8. PubMed ID: 12680174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of Kaposi's Sarcoma herpesvirus (HHV8) in Västerbotten County, Sweden.
    Tedeschi R; Bidoli E; Agren A; Hallmans G; Wadell G; De Paoli P; Dillner J
    J Med Virol; 2006 Mar; 78(3):372-8. PubMed ID: 16419115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Update on Kaposi's sarcoma].
    Morand JJ; Lightburn E; Simon F; Patte JH
    Med Trop (Mars); 2007 Apr; 67(2):123-30. PubMed ID: 17691428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [HHV-8 infection in renal transplantation].
    Lebbé C
    Nephrologie; 2001; 22(6):313-5. PubMed ID: 11715609
    [No Abstract]   [Full Text] [Related]  

  • 33. Control of human herpes virus type 8-associated diseases by NK cells.
    Sirianni MC; Campagna M; Scaramuzzi D; Carbonari M; Toschi E; Bacigalupo I; Monini P; Ensoli B
    Ann N Y Acad Sci; 2007 Jan; 1096():37-43. PubMed ID: 17405914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 in maternal saliva and breast milk in Zambia: implications for transmission.
    Brayfield BP; Kankasa C; West JT; Muyanga J; Bhat G; Klaskala W; Mitchell CD; Wood C
    J Infect Dis; 2004 Jun; 189(12):2260-70. PubMed ID: 15181574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human herpesvirus-8 infection and Kaposi's sarcoma after liver and kidney transplantation in different geographical areas of Spain.
    García-Astudillo LA; Leyva-Cobián F
    Transpl Immunol; 2006 Dec; 17(1):65-9. PubMed ID: 17157220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kaposi's sarcoma: an update.
    Schwartz RA
    J Surg Oncol; 2004 Sep; 87(3):146-51. PubMed ID: 15334644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Latent and lytic HHV-8 mRNA expression in PBMCs and Kaposi's sarcoma skin biopsies of AIDS Kaposi's sarcoma patients.
    Polstra AM; Goudsmit J; Cornelissen M
    J Med Virol; 2003 Aug; 70(4):624-7. PubMed ID: 12794727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pleiotropic effects of Kaposi's sarcoma herpesvirus.
    Schulz TF
    J Pathol; 2006 Jan; 208(2):187-98. PubMed ID: 16362980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human herpes virus 8 infection in kidney transplant patients from an area of northwestern Italy (Piemonte region).
    Bergallo M; Costa C; Margio S; Sidoti F; Re D; Segoloni GP; Cavallo R
    Nephrol Dial Transplant; 2007 Jun; 22(6):1757-61. PubMed ID: 17353210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis.
    Viejo-Borbolla A; Schulz TF
    AIDS Rev; 2003; 5(4):222-9. PubMed ID: 15012001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.